Neetilekha Choudhury

Neetilekha Choudhury practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Neetilekha Choudhury's NPI, 1962587766, was assigned on October 27, 2006. Neetilekha Choudhury holds Washington license MD00042187.

Neetilekha Choudhury's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Neetilekha Choudhury's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. Neetilekha Choudhury is also affiliated with Harborview Medical Center. The medical group on file is UW Physicians. Dmand AI also links Neetilekha Choudhury to 2 more hospitals, 3 group practices and clinics, 2 medical groups, 1 home health agency and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Neetilekha Choudhury practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Neetilekha Choudhury's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Neetilekha Choudhury is licensed in Washington.

CMS data shows 1,043 Medicare services from Neetilekha Choudhury across 14 procedure codes in 2024, for 212 Medicare patients. Medicare paid $72,239 for them. Every service was in an office.

CMS counts 212 Medicare patients who saw Neetilekha Choudhury in 2024. The largest group is 65 to 74, with 95 patients. 67% of them have high blood pressure, and 53% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Neetilekha Choudhury's median patient age at 59, with 67% women.

In 2024, Neetilekha Choudhury wrote 4,290 Medicare Part D claims for 333 patients. 88% of them were for generic drugs. CMS names the drug for 3,692 of them, across 76 drugs with 11 or more claims each, at $255,932 in total drug cost. In 2023, CMS named 3,222 claims across 72 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Neetilekha Choudhury for performance year 2024, reported through an alternative payment model (APM). Neetilekha Choudhury accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Neetilekha Choudhury as offering telehealth.